1. Home
  2. PNNT vs DERM Comparison

PNNT vs DERM Comparison

Compare PNNT & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennantPark Investment Corporation

PNNT

PennantPark Investment Corporation

N/A

Current Price

$3.04

Market Cap

207.6M

Sector

Finance

ML Signal

N/A

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

N/A

Current Price

$5.21

Market Cap

190.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PNNT
DERM
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.6M
190.3M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
PNNT
DERM
Price
$3.04
$5.21
Analyst Decision
Hold
Strong Buy
Analyst Count
8
4
Target Price
$4.75
★ $13.75
AVG Volume (30 Days)
★ 554.4K
184.1K
Earning Date
11-23-2026
11-11-2026
Dividend Yield
★ 15.95%
N/A
EPS Growth
N/A
★ 34.72
EPS
★ N/A
N/A
Revenue
N/A
★ $61,858,000.00
Revenue This Year
N/A
$25.29
Revenue Next Year
$0.32
$50.00
P/E Ratio
$13.14
★ N/A
Revenue Growth
N/A
★ 10.20
52 Week Low
$2.78
$4.31
52 Week High
$6.58
$9.56

Technical Indicators

Market Signals
Indicator
PNNT
DERM
Relative Strength Index (RSI) 44.26 40.61
Support Level $2.78 $4.79
Resistance Level $3.89 $5.50
Average True Range (ATR) 0.09 0.31
MACD 0.02 0.05
Stochastic Oscillator 59.35 39.67

Price Performance

Historical Comparison
PNNT
DERM

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: